Aethlon Medical, Inc. (AEMD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AEMD Revenue Growth
Revenue Breakdown (FY 2022)
AEMD's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
By Geography
AEMD Revenue Analysis (2014–2025)
As of May 8, 2026, Aethlon Medical, Inc. (AEMD) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2026) recorded $0 in revenue.
Looking at the longer-term picture, AEMD's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $1.6 million in 2014.
Revenue diversification analysis shows AEMD's business is primarily driven by Govt Contract And Grant Revenue (100%). With over half of revenue concentrated in Govt Contract And Grant Revenue, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including XTLB, EKSO (-34.1% YoY), and PRTH (+8.3% YoY). Compare AEMD vs XTLB →
AEMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AEMDCurrent | $0 | - | - | - | |
 XTLB | $451,000 | - | - | -481.6% | |
 EKSO | $13M | -34.1% | +7.6% | -104.1% | |
 PRTH | $953M | +8.3% | +18.7% | 14.8% | |
 TELA | $69M | +12.2% | +35.0% | -49.2% | |
 BAX | $11.2B | +5.1% | -0.7% | -2.7% |
AEMD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-9,341,365 | - |
| 2024 | $0 | -100.0% | $0 | - | $-12,636,568 | - |
| 2023 | $574K | +95.2% | $574K | 100.0% | $-11,898,638 | -2072.0% |
| 2022 | $294K | -55.4% | $294K | 100.0% | $-10,420,885 | -3542.5% |
| 2021 | $659K | +1.4% | $659K | 100.0% | $-7,891,499 | -1197.3% |
| 2020 | $650K | +183.2% | $650K | 100.0% | $-5,929,988 | -912.0% |
| 2019 | $230K | +53.5% | $-2,853,491,000 | -1242674.4% | $-5,999,000 | -2612.5% |
| 2018 | $150K | -61.8% | $-2,485,312,000 | -1661027.2% | $-4,831,000 | -3228.7% |
| 2017 | $392K | -55.8% | $-3,087,274,000 | -787423.3% | $-6,098,000 | -1555.3% |
| 2016 | $887K | +16.3% | $-1,414,965,000 | -159599.6% | $-4,385,000 | -494.6% |
See AEMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AEMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AEMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAEMD — Frequently Asked Questions
Quick answers to the most common questions about buying AEMD stock.
Is AEMD's revenue growth accelerating or slowing?
AEMD TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is AEMD's long-term revenue growth rate?
Aethlon Medical, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is AEMD's revenue distributed by segment?
AEMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.